Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 

[search the news]  
 

Health and Pharmaceutical News Archive

 

                                                                   

 
Search our news archive and pharma companies…

Today's News | Note: News feeds may no longer be available for the articles on this page.

Indian Pharma Primed For Growth 6:11 AM 4/25/2009
Forbes - NY,USA
Growing demand for cheap generic drugs is proving a boon reflected in a 46% year-on-year rise in exports to the US. ...

IMS Health Cuts Pharma Growth Forecast 5:24 AM 4/25/2009
BusinessWeek - USA
Global sales of pharmaceuticals will increase by less than 3.5% in 2009. That's down from a forecast of 5% combined with a number of patent expirations due in 2011 and 2012. ...

India Rejects Roche's Patent Plea On Cancer Drug, Standard Says 4:44 AM 4/25/2009
Bloomberg - USA
Roche Holdings AG filed an infringement petition after Cipla Ltd launched the generic version of Tarceva in India. An court dismissed a patent plea by Roche. ...

EU agency backs Novo's diabetes drug Victoza 5:15 AM 4/24/2009
Reuters - USA
European regulators recommended Novo Nordisk's new type 2 diabetes drug Victoza (liraglutide) be approved three weeks after US experts cast doubt on its safety. ...

Lilly Seen As Winner In Court's Block Of Generic Bone Drug 6:21 PM 4/23/2009
CNNMoney.com - USA
A ruling temporarily blocks Teva Pharmaceutical Industries Ltd from selling a generic version of Eli Lilly & Co's blockbuster osteoporosis drug Evista. The decision rejects key points of Teva's defense of selling the drug before all its patents expire in 2017. ...

Amerisource earnings beat Street, raises forecast 9:45 AM 4/23/2009
Reuters - USA
Drug wholesaler AmerisourceBergen Corp reported a rise in quarterly profit helped by generic drug sales and cost controls. ...

AstraZeneca, Bristol drug faces 3-month FDA delay 8:44 AM 4/23/2009
Reuters - USA
The US FDA wants more time to review the new diabetes drug Onglyza from AstraZeneca Plc and Bristol-Myers Squibb Co. ...

‘Morning After' Pill Cleared for 17-Year-Olds 3:14 PM 4/22/2009
New York Times - United States
Girls and boys age 17 can go to almost any pharmacy, clinic, or hospital to buy Plan B "morning-after" contraceptive pills without a prescription. Plan B has had no effect on abortion or teenage pregnancy rates. Women often fail to take it after having unprotected sex. Perhaps 17 year old girls will know better. ...

Colon Cancer Drug Falls Short in Trial 12:09 PM 4/22/2009
New York Times - United States
Avastin is already a best-selling cancer treatment, but it failed to prevent the recurrence of colon cancer. Success could have increased sales by billions of dollars. Roche may have paid more than necessary for the Genentech shares it did not already own. ...

Elan Posts Loss as Costs Overshadow Tysabri Sales 5:04 AM 4/22/2009
Bloomberg - USA
Elan Corp saw surging sales of its the multiple sclerosis drug Tysabri. That wasn't enough to avert a first-quarter loss larger than the year before. ...

US consumer group, drug companies want Medicaid expanded 5:32 PM 4/21/2009
Reuters - USA
Families USA and the Pharmaceutical Research and Manufacturers of America (PhRMA) push a multimillion-dollar advertising and lobbying campaign to get lawmakers to expand Medicaid insurance. ...

Grapefruit Juice Boosts Anti-Cancer Drug's Effects 3:33 PM 4/21/2009
Forbes - NY,USA
Grapefruit juice boosts the anti-cancer effects of rapamycin according to a small study of 25 patients with advanced solid tumors. ...

Par Pharma settles patent dispute with Reliant 12:45 PM 4/21/2009
Forbes - NY,USA
Par Pharmaceutical Cos settled a patent dispute with Reliant Pharmaceuticals Inc over the abnormal heart rhythm treatment Rythmol SR (propafenone). Par can start selling the generic on Jan 1, 2011 or earlier. ...

Actelion Q1 profit more than doubles, beats poll 5:18 AM 4/21/2009
Reuters - USA
Europe's largest biotech company beat forecasts by more than doubling first-quarter profit. There is demand for Actelion Ltd's top-selling blood pressure drug Tracleer. ...

FDA declines to approve Discovery Lab's lung drug 8:03 AM 4/20/2009
Reuters - USA
The US FDA declined to approve Discovery Laboratories Inc's marketing application for Surfaxin to treat respiratory illness in infants. ...

<- Day Earlier | Today's News


 

FindingHealthOnline | Drug Thesaurus | Brand Names | Generic Names | News Digests | For Industry

You may search any of the key words from this page using the search window at the top.

© 2012 Betterchem.com